跳至主要内容
临床试验/NCT07151729
NCT07151729招募中不适用

Use of Anodal Transcranial Direct Current Stimulation to Enhance Upper Limb Recovery in Stroke

Tan Tock Seng Hospital2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
2
主要终点
Fugl-Meyer Upper Limb

研究概览

简要总结

This will be a randomized, blinded, sham-controlled trial. The medical device used, Soterix Medical 1x1 tDCS stimulator, is capable of delivering either real or sham tDCS and has been used in many randomised controlled trials in stroke patients.

50 patients with subacute stroke and severe upper limb weakness within 8 weeks of stroke on transfer to TTSH stroke rehab wards will be recruited over a period of 10 months. Recruited patients will be randomized into the intervention and control arms in a 1:1 ratio.

详细描述

The primary objective is to determine the clinical efficacy, technical feasibility and safety of anodal tDCS therapy to the unaffected hemisphere in hospitalized subacute stroke patients with severe arm weakness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First ever unilateral ischaemic or haemorrhagic stroke, as documented by CT or MRI scans
  • Age 21-80 years, both males and females
  • Within 8 weeks of stroke onset
  • Severe weakness of one upper limb, defined by a Shoulder Abduction and Finger Extension (SAFE) score < 5 (Medical Research Council grading)
  • Provision of informed consent by patient or a legal guardian in accordance with the local ethics committee guidelines and the Declaration of Helsinki

排除标准

  • Bilateral hemispheric or cerebellar strokes
  • Pre-existing arm pathology (e.g. contracture, severe pain, etc.) on the affected side
  • Presence of brain implants, and previous insertion of external ventricular drains.
  • Metallic implants at the level of the neck, mouth cavity and below are permitted (e.g. Cardiac stents, dental implants, pacemakers and other metallic objects)
  • A history of spontaneous seizures, epilepsy, brain tumour, and cranial surgery
  • Severe cognitive impairment (MOCA Score <10) that would hinder sufficient understanding of the instructions
  • Pregnancy

结局指标

主要结局

Fugl-Meyer Upper Limb

时间窗: At baseline (Day 0) At end of 10 tDCS sessions (Day 10) At 3 months after the 10th tDCS session (Month 3)

Fugl-Meyer Upper Limb

次要结局

  • Streamlined Wolf Motor Function Test (sWMFT)(At baseline (Day 0) At end of 10 tDCS sessions (Day 10) At 3 months after the 10th tDCS session (Month 3))
  • Functional Independence Measure (FIM)(At baseline (Day 0) At end of 10 tDCS sessions (Day 10))
  • EQ5D-5L(At baseline (Day 0) and at 3 months after the 10th tDCS session (Month 3))
  • Rate of Adverse Events from tDCS(Immediately after each tDCS session (total 10 sessions of tDCS))

研究者

发起方
Tan Tock Seng Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验